How to Buy Transmedics Group Stock
Transmedics Group Inc
TransMedics Group, Inc. , a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Transmedics Group stock last closed at $114.57, down 2.07% from the previous day, and has decreased 23.18% in one year. It has overperformed other stocks in the Medical Devices industry by 0.1 percentage points. Transmedics Group stock is currently +108.3% from its 52-week low of $55.00, and -32.33% from its 52-week high of $169.29.
There are currently 34.09M TMDX shares outstanding. The market capitalization of TMDX is $3.91B. In the last 24 hours, 794,000 TMDX shares were traded.
How to Buy Transmedics Group Stock
Wondering how to invest in Transmedics Group stock? Here's how.
- Choose where to buy Transmedics Group stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Transmedics Group stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your investment account: Choose your payment method and add your information.
- Research Transmedics Group stock: The Transmedics Group ticker symbol is TMDX. Is Transmedics Group stock a good investment? Should you buy shares of TMDX? How do TMDX's underlying business fundamentals look? Do top analysts think Transmedics Group is a good buy? Why has TMDX's stock price moved recently? (Hint: Our stock market research website can help you understand if TMDX is a good stock to buy).
- Place your TMDX purchase: Decide if you will purchase TMDX shares at the current market price or use a limit order to buy TMDX stock at a given price.
- Get notifications regarding your TMDX position: Create a watchlist to monitor your investment in Transmedics Group shares.
Step 1: Choose where to buy Transmedics Group stock
You will need an online brokerage account in order to access the NASDAQ market and buy TMDX stock.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in TMDX stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start your new trading account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have opened your account on mobile trading apps, you need to deposit funds:
Check out the video below for more details transferring money into your new brokerage account.
Step 4: Research Transmedics Group stock
Once you have chosen the best place to buy Transmedics Group stock, it's crucial to analyze their stock before you buy, so you truly understand the risk as well as the upside.
Transmedics Group stock data
Transmedics Group Overview
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on TMDX's stock page.
Is TMDX stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge TMDX's fair value.
Using relative valuations metrics:
- TMDX may be overvalued based on its P/E ratio of 53.79x, relative to Medical Devices industry P/E ratio of 31.61x
- TMDX could be overvalued based on its P/B ratio of 12.28x, relative to Medical Devices industry P/B ratio of 4.03x
- TMDX could be overvalued based on its PEG ratio of 2.99x
You can access more valuation research on TMDX's stock here.
TMDX Financial Summary
Passed Health Checks:
- TMDX earnings of $88.22M is not enough to cover its interest payments.
- There are more short-term assets than long-term liabilities on the TMDX balance sheet.
- TMDX profit margin has gone up from 0.8% to 13.5% in the past year.
- There are more short-term assets than short-term liabilities on the TMDX balance sheet.
- TMDX's operating cash flow of $115.27M allows it to safely service it's debt of $518.82M.
Failed Health Checks:
- Total TMDX debt is higher than 5 years ago, relative to shareholder equity.
- TMDX has a relatively high debt to equity ratio of 1.8.
Is Transmedics Group stock a Buy, Hold, or Sell, according to analysts?
Out of 5 Wall Street analysts who give forecasts on TMDX, the consensus analyst rating on TMDX is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Transmedics Group stock forecast page.
TMDX Trading Indicators
How are TMDX Revenues/Earnings doing?
Last year, TMDX earnings were $71.66M. Over the past 1 years, TMDX's earnings have increased by 2,562.5% per year. This was faster than the Medical Devices industry average of 29.2%.
Last year, TMDX revenue was $531.29M. During the past 5 year, TMDX's revenue has gone up by 85.51% per year. This was faster than the Medical Devices industry average of 10.44%.
You can research TMDX's earnings and revenue performance here.
Are TMDX insiders buying or selling the stock?
Over the last year, insiders at TMDX have bought more shares than they have sold.
Waleed H. Hassanein, President CEO of TMDX, was the latest TMDX insider to buy. They bought $768,101.36 worth of TMDX shares on Aug 7, 2025.
Dig into more about who owns TMDX shares here.
Can I get consistent income from TMDX stock?
No, Transmedics Group doesn't provide an income stream by paying out dividends.
TMDX Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your TMDX purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Click the Open button and your broker will execute your order.
If you need more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your TMDX position
Now that you own some shares in TMDX, you'll want to keep up with your new shares.
Create a watchlist to monitor your TMDX stock.
TMDX Feed
How to Buy Stock in Transmedics Group
To reiterate, here are the 6 steps for buying Transmedics Group stock:
- Choose where to buy Transmedics Group stock
- Create your brokerage account
- Fund your investment account
- Research Transmedics Group stock
- Place your TMDX purchase
- Get notifications regarding your TMDX position
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your investment in Transmedics Group, create a watchlist on WallStreetZen today.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.